CJC-1295, 2mg/vial
Molecular Formula:C165H269N47O46
Molecular Weight:3647.15
CAS No.:863288-34-0
Specification:2mg*10vials/kit
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(maleimido)
Usage: An obstetric drug used to control postpartum hemorrhaging.
CJC-1295 is an injectable peptide used to increase GH production. This peptide is a hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and
may be referred to as being a GHRH.
The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain
as well. Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span
of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a
scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse.